Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library

Items published during the years 1980 to 1989

There are 1082 items in the Healthy Skepticism Library that were published during the years 1980 to 1989.

Page 11 of 11 pages ‹ First  < 9 10 11

Meadows R.
Communicating new drug information—the medium is the message
Drug Information Journal 1981; 15:11-15

Parsons LJ, Abeele PV.
Analysis of sales call effectiveness
Journal of Marketing Research 1981; 18:107-113

Schneiweiss F.
Pharmaceutical advertising and the medical journal
Drug Information Journal 1981; 15:193-197

Seaman B, Seaman G.
Women and the crisis in sex hormones

Silverman M, Lydecker M.
The promotion of prescription drugs and other puzzles
1981; 78-92

Tennent RB.
Trade representatives
New Zealand Medical Journal 1981; 93:314

Drug and Therapeutics Bulletin
British Journal of Hospital Medicine 1981; 25:309

Turner P.
Drug and Therapeutics Bulletin
Drug and Therapeutics Bulletin 1981; 25:309

Nordahl V.
Analgetics sales without prescription-should the selection and consumption be changed?
Norsk Farmaceutisk Tidsskrift 1981; 89:(1-2):4-7

Melrose D.
The Great Health Robbery
: Oxfam 1981

Leffler K
Persuasion or information? the economics of prescription drug advertising.
J Law Econ 1981; 24:45–74

Ross V.
Between bliss and bedlam
Maclean’s (Toronto) 1980 Dec 838-40, 42, 44

Hemminki E, Falkum E.
Psychotropic drug registration in the Scandinavian countries: the role of clinical trials.
Soc Sci Med [Med Psychol Med Sociol] 1980 Dec; 14A:(6):547-59

Strickland-Hodge B, Jeqson MH.
Usage of information sources by general practitioners.
J R Soc Med 1980 Dec; 73:(12):857-62

Bush PJ.
Prescribing is a social process
1980 Nov; 1:VIII-X

Relman AS.
The new medical-industrial complex.
N Engl J Med 1980 Oct 23; 303:(17):963-70

Makers campaign harder for votes of RPhs dispensing generically
American Druggist 1980 Oct; 182: 44, 46, 48, 50, 52, 56, 58, 6

Fink JL.
FDA's dispensing container specifications and the pharmacist
Pharm Manage 1980 Sep-Oct; 152:197-198

Peart WS.
The pharmaceutical industry: research and responsibility.
Lancet 1980 Aug 30; 2:(8192):465-6

Epstein P, Yudkin JS.
Agranulocytosis in Mozambique due to amidopyrine, a drug withdrawn in the west.
Lancet 1980 Aug 2; 2:(8188):254-5

de Andrade CD
O Homem e o Remédio: Qual o problema (People and medicines: What's wrong?)
Jornal do Brasil 1980 July 26

Gambrill J, Bridges-Webb C.
Use of sources of therapeutic and prescribing information by general practitioners.
Aust Fam Physician 1980 Jul; 9:(7):482-4

Siskind V.
Prescription drug advertising
Medical Journal of Australia 1980 Jun 14; 67:615, 617

Johnston TS.
Provision of medicines in Ecuador.
Lancet 1980 May 17; 1:(8177):1073-4

Palmisano P, Edelstein J.
Teaching drug promotion abuses to health profession students.
J Med Educ 1980 May; 55:(5):453-5

King E.
Sex bias in psychoactive drug advertisements.
Psychiatry 1980 May; 43:(2):129-37

Manning PR, Denson TA.
How internists learned about cimetidine.
Ann Intern Med 1980 May; 92:(5):690-2

Joan SW.
Keeping prescription drug advertising honest: FDA's watchful eye
American Pharmacy 1980 May; 20:(5):40-44

Woody E Jr.
The paradox of pharmaceutical advertising.
J Med Assoc Ga 1980 May; 69:(5):379

Hemminki E.
Study of information submitted by drug companies to licensing authorities.
Br Med J 1980 Mar 22; 280:(6217):833-6

Babich F, Moore J.
Prescription drug advertising
Medical Journal of Australia 1980 Mar 22; 67:282

Glaser M.
Healthy drug market forecast for 1980
Drug Topics 1980 Mar 14; 124:47-48, 61

Bell RW, Osterman J.
The Compendium of Pharmaceuticals and Specialties: a critical analysis
1980 Mar; 19

York P.
Ujamaa (participatory socialism) for pharmacy in Tanzania
Pharm Int 1980 Mar; 1:8-11

Wolfe SM.
Real targets: doctors, drug firms
FDA Consumer 1980 Feb; 14:13

Goyan JE.
Who reviews the ads?
N Engl J Med 1980 Jan 31; 302:(5):296

Thron CD.
Who reviews the ads?
N Engl J Med 1980 Jan 31; 302:(5):295

Youman JD.
Who reviews the ads?
N Engl J Med 1980 Jan 31; 302:(5):295

Young RS.
Who reviews the ads?
N Engl J Med 1980 Jan 31; 302:(5):295-6

Stinson ER, Mueller DA.
Survey of health professionals' information habits and needs. Conducted through personal interviews
JAMA. 1980 Jan 11;243(2):140-3 1980 Jan 11; 243:(2):140-3

Kane RE.
Environmental analysis of the prescription drug industry
Drug Information Journal 1980 Jan 3; 14:20-23

Walton H.
Ad Recognition and Prescribing by Physicians
Journal of Advertising Research 1980; 20:(3):39-48

Ethics and drug ads—a slip up in Bangladesh
1980; 208:268-269

Colville P.
New material for medical representatives pharmacology course
Pharmaceutical Journal of New Zealand 1980; 42:(6):5-7

Darvall LW.
The pharmaceutical industry: Prescription drug information controls in Australia and the United States
Monash University Law Review 1980; 7:39-51

Gray BV.
Trade displays at medical conferences
New Zealand Medical Journal 1980; 92:401

Hibberd P.
Use of drug information sources by hospital doctors
Journal of Information Science 1980; 2:169-172

Hurd P.
The potential value of unfavorable information
Medical Marketing & Media 1980; 15:(5):42-44, 46

Hutchinson G.
Prescribing drugs—generic vs trade names
McGill Medical Journal 1980; 46:(1):2-6

Hymans R.
Trade displays at medical conferences
New Zealand Medical Journal 1980; 92:329-330

Kellen A, Vandor T.
Commercial interruptions
Canadian Medical Association Journal 1980; 123:12

Rheinstein P, Baum CS.
Labeling effectiveness and the health environment
1980; 6:275-287

Rivin AU.
"Ethical" drugs.
Pharos Alpha Omega Alpha Honor Med Soc 1980 Spr; 43:(2):9-10

Stephenson PS, Walker GA.
Psychotropic drugs and women
Bioethics Quarterly 1980; 2:(1):20-38

Woods D.
And now, a word for our sponsor . . .
Canadian Medical Association Journal 1980; 122:1343

Yudkin JS.
The economics of pharmaceutical supply in Tanzania.
Int J Health Serv 1980; 10:(3):455-77

Conrad P, Schneider JW.
Deviance and Medicalization: From Badness to Sickness
St Louis: Mosby/Temple University Press 1980

Temin P.
Taking Your Medicine: Drug Regulation in the US
: Harvard Univ Press 1980

Chapman S
Not biting the hand that feeds you. Tobacco advertising and editorial bias in Australian newspapers.
MJA 1984 14; 480

Axsom D, Yates S, Chaiken S.
Audience response as a heuristic cue in persuasion.
J Pers Soc Psychol 1987; 53:(1):30-40

Avorn J, Soumerai SB
Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based 'detailing'.
NEJM 1983 16; 308:(24):1457

Arkes HR.
Impediments to accurate clinical judgment and possible ways to minimize their impact.
J Consult Clin Psychol 1981; 49:(3):323-30

Morgan PP.
Are physicians learning from what they read in journals?
Can Med Assoc J 1985 15; 133:(4):263

Kunin CM, Lipton HL, Tupasi T, Sacks T, Scheckler WE, Jivani A, Goic A, Martin RR, Guerrant RL, Thamlikitkul V.
Social, behavioral, and practical factors affecting antibiotic use worldwide: report of Task Force 4.
Rev Infect Dis 1987; 9:

Kieburtz KD, Johnson RE.
Prescribing rate of internists in an HMO and the influence of information sources.
GHAA J 1986; 7:(1):60-71

Gruppen LD, Wolf FM, Van Voorhees C, Stross JK.
The influence of prior experience and confidence on physician preferences for information sources and continuity of care.
Res Med Educ 1986; 25:177-82:

Fuhrer MJ, Grabois M.
Information sources that influence physiatrists' adoption of new clinical practices.
Arch Phys Med Rehabil 1988; 69:(3):

Friedlander ML, Stockman SJ.
Anchoring and publicity effects in clinical judgment.
J Clin Psychol 1983; 39:(4):637-43

Elstein AS, Holmes MM, Ravitch MM, Rovner DR, Holzman GB, Rothert ML.
Medical decisions in perspective: applied research in cognitive psychology.
Perspect Biol Med 1983; 26:(3):486-501

Davidoff F.
Patient management problems: heuristics and biases.
Med Decis Making 1988; 8:(2):87-9

Cohen SJ, Weinberger M, Mazzuca SA, McDonald CJ.
Perceived influence of different information sources on the decision-making of internal medicine house staff and faculty.
Soc Sci Med 1982; 16:(14):1361-4

Soumerai SB, Avorn J.
Economic and policy analysis of university-based drug 'detailing'
Med Care 1986; 24:(4):313-31

Tucker PP, Tucker GK.
A comparison of hospital chief executive officers, and hospital pharmacy directors' attitudes toward drug product appeals.
J Pharm Mark Manage 1988; 2:(4):101-11

Weinberger M, Mazzuca SA, Cohen SJ, McDonald CJ.
Physicians' ratings of information sources about their preventive medicine decisions.
Prev Med 1982; 11:(6):717-23

Wolf FM, Gruppen LD, Billi JE
Differential diagnosis and the competing-hypotheses heuristic. A practical approach to judgment under uncertainty and Bayesian probability.
JAMA 1985 17; 253:(19):2858

Mackie DM, Worth LT.
Processing deficits and the mediation of positive affect in persuasion.
J Pers Soc Psychol 1989; 57:(1):27-40

Mansfield PR
Drug Marketing in the Third World
National News The Royal College of General Practitioners 1984 Aug

MLAM rallies health care activists against 'inappropriate' marketing
International Barometer 1985 Nov1 & 3

Ideas for Action: MLAM
New Internationalist 1984 Apr29

Kong A, Barnett GO, Mosteller F, Youtz C.
How medical professionals evaluate expressions of probability.
N Engl J Med 1986 18; 315:(12):740-4

Nelkin D.
How to doctor the media.
New Sci 1986 20; 112:(1535):51-6

Frauenfelder J, Bungey J.
The inappropriate use of prescription medicine.
Community Health Stud 1985; 9:(1):10-8

Page 11 of 11 pages ‹ First  < 9 10 11


  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Click to Register

(read more)

Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts

If there is something you don't like, please tell us. If you like our work, please tell others.

Far too large a section of the treatment of disease is to-day controlled by the big manufacturing pharmacists, who have enslaved us in a plausible pseudo-science...
The blind faith which some men have in medicines illustrates too often the greatest of all human capacities - the capacity for self deception...
Some one will say, Is this all your science has to tell us? Is this the outcome of decades of good clinical work, of patient study of the disease, of anxious trial in such good faith of so many drugs? Give us back the childlike trust of the fathers in antimony and in the lancet rather than this cold nihilism. Not at all! Let us accept the truth, however unpleasant it may be, and with the death rate staring us in the face, let us not be deceived with vain fancies...
we need a stern, iconoclastic spirit which leads, not to nihilism, but to an active skepticism - not the passive skepticism, born of despair, but the active skepticism born of a knowledge that recognizes its limitations and knows full well that only in this attitude of mind can true progress be made.
- William Osler 1909